Skip to content

Fractional Flow Reserve Fax Registry

A Fax-based Registry Regarding Clinical Indications, Complication Rates and Management Consequences of Invasive Fractional Flow Reserve Measurements

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03055910
Acronym
F(FR)²
Enrollment
2000
Registered
2017-02-16
Start date
2017-03-01
Completion date
2018-01-31
Last updated
2017-02-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Artery Disease

Brief summary

The Fractional Flow Reserve Fax Registry is an investigator-initiated, real-world registry to analyze the use of fractional flow reserve (FFR) measurements in clinical practice in cardiac catheterization laboratories in Germany. The registry aims to collect the data of 2000 patients who underwent FFR recordings for clinical reasons. The main outcome parameter is the frequency of coronary revascularization following FFR. Secondary outcome parameters include the distribution of quantitative FFR results in clinical practice, the influence of intracoronary versus intravenous adenosine on the distribution of FFR results, the rate of complications as a result of FFR measurements, the average number of FFR wires needed per patient. Since the study will include a large number of patients who undergo i.c. administration of adenosine and a large number of patients who undergo i.v. administration of adenosine, it will be possible to analyze whether the route of adenosine administration is an independent predictor of the FFR result.

Detailed description

Patient Inclusion Criteria All patients who undergo measurement of the Fractional Flow Reserve using intracoronary pressure measurements for clinical reasons are eligible for inclusion. There are no exclusion criteria. Methods Following a clinically indicated FFR measurement, patient data and data concerning angiographic stenosis severity as well as anatomic location of the interrogated lesion, method of adenosine administration, and FFR result are documented in a paper form. The form contains no patient data except age and gender as well as the cath lab identifying number and the serial number of the used FFR wire(s). The paper form is transmitted by fax to the central study site at Erlangen University where data will be stored and all evaluations will be performed. Recruitment period Recruitment starts March 1, 2017 and will be terminated after 2000 patients have been included. Number of patients 2000 patients will be included. Outcome parameters The main outcome parameter is the frequency of coronary revascularization following FFR. Secondary outcome parameters include the distribution of quantitative FFR results in clinical practice, the rate of complications as a result of FFR measurements, and the average number of FFR wires needed per patient, as well as the influence of i.c. versus i.v. administration of adenosine on the distribution of obtained FFR results. All outcome parameters will be determined immediately after the end of invasive coronary angiography (and coronary intervention, if performed) in each patient (day 0). No follow-up will be performed. Institutional Review Board (IRB) The study protocol has been approved by the IRB of the Faculty of Medicine, University of Erlangen-Nürnberg (File Number 4\_15B). Patient consent has been waived since data will be completely anonymized and no study-specific interventions are performed. Primary Investigator The study primary investigator is Stephan Achenbach Department of Cardiology University of Erlangen Ulmenweg 18 91054 Erlangen Germany The study co-primary investigator is Helge Möllmann Department of Cardiology Johannes Hospital Dortmund Johannesstraße 9-13 44137 Dortmund Germany Sponsor The study is sponsored by the University Hospital Erlangen, Department of Cardiology. It is financed through a restricted grant by Abbott Vascular

Interventions

Wire-based invasive measurement of the fractional flow reserve in the context of coronary angiography and percutaneous coronary intervention in order to assess the hemodynamic relevance of coronary artery stenoses

Sponsors

Abbott Medical Devices
CollaboratorINDUSTRY
University of Erlangen-Nürnberg Medical School
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* invasive fractional flow reserve measurement is performed for clinical reasons

Exclusion criteria

* none

Design outcomes

Primary

MeasureTime frameDescription
Revascularization1 hourRate of revascularization following measurement of the fractional flow reserve

Secondary

MeasureTime frameDescription
Complications1 hourComplication attributable to the invasive measurement of fractional flow reserve
Number of wires1 hourNumber of FFR wires used per patient
Administration route1 hourAverage FFR values obtained in the cohort when using intracoronary or intravenous injection of adenosine

Countries

Germany

Contacts

Primary ContactStephan Achenbach, MD
stephan.achenbach@uk-erlangen.de++4991318535301
Backup ContactGrit Herrmann
grit.herrmann@uk-erlangen.de++4991318535301

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 11, 2026